142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

Implementation of the ACA in California: Is Latino Enrollment a Success Story?

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 2:30 PM - 2:50 PM

Shana A. Lavarreda, PhD, MPP , Center for Health Policy Research, UCLA, Los Angeles, CA
When the March 31st deadline passed, Covered CA announced that it had exceeded its target for Latino Enrollment. However, the story of Latino enrollment in California is more nuanced, from delays in releasing the application in Spanish to a backlog of applications for Medi-Cal enrollment, along with exclusions for undocumented immigrants. The latest administrative data from CA will be discussed.

Learning Areas:

Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health or related public policy

Learning Objectives:
Identify the eligibility criteria for enrollment in ACA health insurance expansions that pertain to Latinos. Discuss the impact of decisions made by Covered CA regarding ACA implementation that affected Latinos. Describe the growth in health insurance among Latinos in CA due to the ACA.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been co-PI on numerous studies related to health insurance and access to care, with a focus on immigration status and legal requirements to access public health insurance. I have also been an invited speaker at the NIH regarding surveys on immigration status and have presented numerous times at national and international conferences on the intersection of immigration and health insurance in the U.S. I am also an expert regarding the Affordable Care Act.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.